GILEAD SCIENCES

TRUVADA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

GILEAD SCIENCES

Truvada HCPCS:

J0751

HCPCS Code Descriptor:

Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

Category:

J Code

Truvada NDCs:

61958-2002-01, 61958-2002-02

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Oral

Truvada CPT Codes:

Potential CPT administration codes for Truvada can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Truvada:

TRUVADA is a Anti-HIV drug manufactured by and administered via the Oral route of administration. The J Code: J0751 is aligned to the drug TRUVADA.

Truvada is a medication used as a pre-exposure prophylaxis for HIV. It is prescribed to those who are deemed high risk for contracting infection. Truvada comes in a variety of formulations, this version contains a combination of two medications: emtricitabine 200 mg and tenofovir alafenamide 25 mg.

ACCESS PRICING AND MORE BY REGISTERING

J0751 Added Date:

January 2, 2024

J0751 Effective Date:

January 2, 2024

J0751 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Truvada billing and coding information.
Our team did not identify a source for Truvada patient assistance information. Please reach out to our team if you feel that this is a mistake.
TRUVADA prescribing information can be found at the link below:
Information regarding TRUVADA’s side effects can be found at MedlinePlus